Roxana Mehran, MD, FACC, is an endowed professor of cardiovascular clinical research and outcomes and a professor of medicine (cardiology) and population health science and policy at the Icahn School of Medicine at Mount Sinai. Mehran completed fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center, where she was also named Director of the Women’s Heart and Vascular Center at Mount Sinai Fuster Heart Hospital, spearheading a program designed to meet the unique needs of women’s cardiovascular health.
Mehran has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participated in development of clinical guidelines and authored more than 2,000 peer-reviewed articles. She is also leading the Lancet Commission on Women’s Cardiovascular Diseases. With over 2,300 published manuscripts, Mehran was named by Clarivate Analytics as one of the most influential scientific minds in their Highly Cited Researchers list for the past eight years. She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation and the founder of Women as One.
At the ACC, Mehran has served as Chair of the Interventional Section Leadership Council and has been an author on several revascularization and dual antiplatelet therapy guidelines. She has also been active in the Society for Cardiovascular Angiography and Interventions, where she served as Program Chair of the 2016 Scientific Sessions and co‑founded the Women in Innovations Committee.
Mehran’s honors include the 2017 ACC Bernadine Healy Leadership in CV Disease Award, the 2018 Nanette Wenger Award for Excellence in Medical Leadership from WomenHeart, the Ellis Island Medal of Honor (2019) and the ESC Silver Medal with the Andreas Grüntzig Lecture (2019). In 2022 she received the Terry Ann Krulwich Physician-Scientist Alumni Award, PulseSetter Champion Award and AHA Women in Cardiology Mentoring Award; in 2023, she received the ACC Bahr Award of Excellence.
